This site is intended for healthcare professionals only
LoginRegister
After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug NereusAlembic Pharma bags USFDA okay for blood cancer drug Bosutinib
Sun Pharma Sets Record with Over 1 Lakh Uric Acid Screenings in 3 DaysSun Pharma Sets Record with Over 1 Lakh Uric Acid Screenings in 3 Days
AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia TreatmentAstraZeneca gets CDSCO nod for new indications of Benralizumab, Osimertinib in India
CDSCO Committee Recommends SpinoS to Conduct BE Study with Vitamin D Screening ConditionsCDSCO Committee Recommends SpinoS to Conduct BE Study with Vitamin D Screening Conditions
Roche Lunsumio subcutaneous secures European Commission approval for refractory follicular lymphomaMarksans Pharma arm adds Metformin Hydrochloride 500mg/ 5 ml Oral Solution to growing list of UK...
No Promotional Campaigns for GLP-1 Obesity Drugs: CDSCO Cautions Pharma FirmsOnly Licensed Importers Can Overprint Labels Under Rule 104A, Clarifies CDSCO
Jayeeta Chatterjee joins Sandoz as Head - HCM TransformationSandoz: Jayeeta Chatterjee appointed as Head - HCM Transformation
Aurobindo Pharma Gets 5 USFDA Observations for Unit-IV FacilityAurobindo Pharma arm Curateq Biologics incorporates new wholly owned subsidiary in Netherlands
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosusAstraZeneca Imfinzi recommended for approval in EU for adults with muscle-invasive bladder cancer
Eli Lilly to acquire SiteOne Therapeutics in USD 1 billion dealEli Lilly to acquire SiteOne Therapeutics in USD 1 billion deal
Anar Modi named CHO at Senores PharmaAnar Modi named CHO at Senores Pharma
USFDA Approves Bionpharmas Generic HIV Drug EtravirineBayer Sevabertinib gets USFDA Priority Review status for HER2-mutant non-small cell lung cancer
X